IVM IVF/ICSI nin YERİNİ ALACAK MI ?

Slides:



Advertisements
Similar presentations
In Vitro Fertilization
Advertisements

New Developments in Assisted Reproduction
Luteal Phase Support in ART Cycles
 OHSS is a serious, potentially life- threatening, iatrogenic complication of “controlled” ovarian stimulation.  To optimize the ovarian response without.
PREVENTION OF MULTIPLES FROM A CLINICIAN’S STANDPOINT Bulent Urman M.D. American Hospital of Istanbul.
ART-IVF: the Long and Short of it Professor Ernest Hung Yu NG Department of Obstetrics & Gynaecology The University of Hong Kong.
IOGENESI Centro di Medicina della Riproduzione B Laboratory aspects of IVM DAL CANTO MARIABEATRICE BIOGENESI REPRODUCTIVE MEDICINE CENTER, ISTITUTI CLINICI.
Elonva in poor responders
Minimal Monitoring of Ovulation Induction (OI) Is It Safe? Mustafa Uğur Zekai Tahir Burak Women’s Health Education and Research Hospital, Ankara, Turkey.
Assisted Reproductive Techniques IUI (intrauterine insemination) AIH (artificial insemination by husband) AID (artificial insemination by donor) IUI (intrauterine.
LIFE AFTER NEW IVF LEGISLATION IN TURKEY Hakan Ozornek, MD EUROFERTIL Istanbul.
INDIVIDUALIZED IVF TREATMENT
The Women’s Clinic 婦產科中心 Current Criticism on IVM Treatment Dr. Milton Leong MDCM DSc (McGill) Director, IVF Center, Hong Kong Sanatorium & Hospital Specialist.
History and Fundamentals of Oocyte Maturation in Vitro
OVARIAN STIMULATION: WHEN DOES LESS ACHIEVE MORE? Milton K.H. Leong, M.D. IVF Centre Hong Kong Sanatorium & Hospital, China Overview and Introduction.
The Women’s Clinic 婦產科中心 New Concept of Controlled Ovarian Stimulation in IVF Dr. Milton Leong MDCM DSc (McGill) Director, IVF Center, HKSH Specialist.
WHAT IS IVF? In vitro fertilization (IVF) is a process by which egg cells are manually fertilized by sperm outside of the womb. IVF is a major treatment.
Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
In Vitro Fertilization by Ms. Mann. Assessment Statements Outline the process of in vitro fertilization (IVF) Discuss the ethical issues associated.
IVM is ready as a treatment for PCOS patients
Discontinuation of rLH two days before hCG may increase the number of oocytes retrieved in IVF Jessica B Spencer 1*, Aimee S Browne 1, Susannah D Copland.
Comparison Of Letrozole And Clomiphene Citrate Saima Ahmad MRCOG Riaz Medical Center Sharjah. UAE Objectives Conclusions Competing Interest References.
Does exogenous LH activity influence the outcome in IVF and not in ICSI cycles? Peter Platteau, Johan Smitz, Carola Albano, Per Sørensen Joan-Carles Arce.
Objectives Polycystic ovary syndrome (PCOS) is characterized by chronic anovulation and hyperandrogenism and affects approximately 5–10% of women of reproductive.
Hong Kong Sanatorium & Hospital, China
TEMPLATE DESIGN © Oocyte donation outcomes at Alpha International Fertility Centre IntroductionResultsConclusions References.
Planning of GnRH antagonist cycles
Treatment Options for Infertility
Hakan Özörnek EUROFERTIL IVF Center Turkey.  No or minimal stimulation  Low cost  Less monitoring  Less side effects (OHSS)  Acceptable pregnancy.
The Women ’ s Clinic 婦產科中心 IVM/IVF in PCOS (PCO-Like Ovaries) Milton Ka Hong Leong MDCM DSc(McGill) FRCS(C) FRCOG FACOG FHKCOG Director, IVF Centre HK.
Dr. Milton Leong Director
The Effect of Bromocriptine-Rebound Method on Ongoing Pregnancy and Live Birth after Intracytoplasmic Sperm Injection Cycles: a Randomized Clinical Trial.
The 4th Misurata scientific meeting of infertility Benghazi – Libya 10/10/2008 Dr. Omar A. Elsraiti Consultant of Obst. & Gyn. IVF Centre - Misurata /
IVF - ICSI ÖNCESİ ENDOMETRIOMALAR ÇIKARTILMALI MI? Prof. Dr. Bülent Baysal İ.Ü. İstanbul Tıp Fakültesi.
SL ‘00 Antagonists in patients with previous poor ovarian response Antagonists in patients with previous poor ovarian response Geoffrey H Trew Consultant.
Agonist vs Antagonist Dr. Milton Leong.
How to schedule GnRH antagonist cycles?
Recommended Dosage of GnRH Antagonist is Too High Presented by Dr. Milton Leong, MD DSc(McGill) Director, IVF Centre.
Aline de Cássia Azevedo (a,b) ; Fernanda Coimbra Miyasato (b) ; Litsuko S. Fujihara (b), Maria Cecília R.M. Albuquerque (b), Ticiana V. Oliveira (b), Luiz.
Endometrial scratching performed in the non-transfer cycle and outcome of assisted reproduction: a randomized controlled trial CO Nastri, RA Ferriani,
Methods of assisted reproduction MUDr.Jitka Řezáčová ÚPMD, Praha 4, Podolí.
ART FOR PCOS-DIFFICULTIES AND SOLUTIONS Dr. Bulent Urman American Hospital, ISTANBUL Assisted Reproduction Unit Koç University, Faculty of Medicine Department.
A review on the luteal phase P Devroey MD PhD Centre for Reproductive Medicine Dutch-speaking Brussels Free University Brussels - Belgium.
Luteal coasting post GnRH agonist trigger
Methods Interleukim6,Interleukin 1 ,Estradiol and Testosterone Concentrations in Serum and Follicular Fluid of females with stimulated and non-stimulated.
Solutions to Infertility Reproductive Technologies.
In-vitro maturation: patient selection and results Aygul Demirol Assoc Prof, Medical Director GURGAN CLINIC IVF Center, Ankara-Turkey.
© Fertility Centers of Illinois1 Freeze-All Policy: Fresh vs. Frozen- Thawed embryo transfer in PCOS patients Jane Nani, M.D. November 17, 2015.
Georg Griesinger UK-SH, Campus Luebeck Germany. We have a problem…
(Miz Medi Hospital) Jung-Hyun Cho, M.D. (Miz Medi Hospital) Minimal Ovarian Stimulation.
PKOS’unda GnRH anolog vs. antagonist Dr.Engin Oral İ.Ü. Cerrahpaşa Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı Reprodüktif Endokrinoloji Bilim.
IVF TROUBLESHOOTING ( Clinical Perspective) Malvin Emeraldi M. Luky, Dianing ASR,Muchsin J Family Fertility Center, RSIA Family Fatmawaty Hospital Jakarta,
ART & Fertility Massage Clare Blake N.D. Fertility Massage Therapy & Training.
Fertility Facts Definition:unprotected sex for one year, not pregnant
Vikram Talaulikar, Melanie Davies & Gerard S Conway
ART’de Aşırı Cevabın Yönetimi
How IVF Protocols Work to Enhance the Success of IVF: Agonist vs Antagonist Dr Dimitrios Dovas MD Newlife IVF Greece.
Facilitator: Pawin Puapornpong
ultrasound of the female pelvis
Ovarian Hyper Stimulation Syndrome (OHSS)
Oocyte retrieval at 140 mm Hg negative aspiration pressure – a promising alternative to flushing and aspiration in Assisted Reproduction Dr.Aswathy Kumaran**
Use of GnRH antagonists for IVF
Mohamed Elmahdy MD. Lecturer Obs. Gyn. Alexandria University Egypt
The approach to the PCOS patient undergoing IVF
Pregnancy outcomes after assisted reproductive procedures of embryos derived from affected and unaffected ovaries among women with small unilateral endometriomas.
Supplemental Table 2. Reproductive outcomes
The effect of the duration of stimulation on ART outcomes
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
Ovarian stimulation protocols for IVF: is more better than less?
Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf 
Presentation transcript:

IVM IVF/ICSI nin YERİNİ ALACAK MI ? SLIDE 6 Standart ART Cycle Prof Dr Bülent GÜLEKLİ Dokuz Eylül Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum ABD Başkanı Reprodüktif Endokrinoloji ve IVF Bilim Dalı Öğretim Üyesi

Cumulative conception rate (%) n: 4777 IVF cycles Cumulative conception rate (%) SLIDE 2 Today in vitro fertilization and embryo transfer is an established and successful form of treatment for infertility. It has been reported that for women below 34 years old the cumulative pregnancy and live birth rate after 3 cycles of IVF treatment were 63 and 61 percent respectively. These data suggest that pregnancy and live birth rates may actually be higher after IVF than natural conception in fertile couples. Such those high success rates with IVF are achieved by replacing more than one embryo which requires to get plenty oocytes Number of cycles / month Tan et.al Lancet 1990

IVF treatment with ovarian stimulation Ovarian stimulation with protocols involving GnRH agonist or antagonist in combination with gonadotrophins More oocytes available for insemination Success rates related to the number of embryos available for transfer Initially designed for tubal factor infertility, but currently used for other indications Good pregnancy rates SLIDE 6 Standart ART Cycle

Early studies on IVM of human oocytes Rock and Menkin (1944): Science, 100:105-107. Edwards (1965): Nature, 208:349-351. - matured human oocytes from antral follicles Kennedy and Donahue (1969): Science, 164:1292-1293. SLIDE 6 Standart ART Cycle ‘An alternative to the hyperstimulatory techniques is oocyte-maturation in-vitro’ – John Eppig (1989, Nat. Acad. Sci.)

Immature oocytes from unstimulated ovaries (Egg donation) Cha et al. (1991): Fertil. Steril., 55:109-113. – birth of healthy twins Cha et al. (1992): Reprod. Fertil. Dev., 4:695-701. Hwang et al. (1997): Fertil. Steril., 68:1139-1140 SLIDE 6 Standart ART Cycle

Immature oocytes from unstimulated ovaries (Oocytes from natural cycles) Paulson et al. (1992): Fertil. Steril., 57:290-293. Paulson et al. (1994): Hum. Reprod., 9:1571-1575. Thornton et al. (1998): Fertil. Steril., 70:647-650. SLIDE 6 Standart ART Cycle

Development of the follicle Follicular growth Stage Follicular size (mm) Primordial 0.03 – 0.04 Primary 0.05 – 0.06 Secondary 0.07 – 0.11 Preantral 0.12 – 0.20 Early antral 0.21 – 0.40 Antral 0.41 – 16.00 Preovulatory 16.10 – 20.00 SLIDE 6 Standart ART Cycle Gougeon, A. (1986): Hum. Reprod., 1:81-87.

Why IVM is an alternative treatment option? Recovery of immature oocytes followed by IVM is a potentially useful treatment for patients with infertility Women with polycystic ovaries (PCO) or polycystic ovarian syndrome (PCOS) have a slightly higher risk of developing ovarian hyperstimulation syndrome (OHSS) SLIDE 6 Standart ART Cycle

Advantages of IVM for infertile patients Avoidance of side effects resulting from gonadotrophin stimulation, including OHSS To simplify treatment, especially for the women Reduced cost Rescue early follicles SLIDE 6 Standart ART Cycle

Selection criteria for IVM patients Patients with PCO or PCOS, irregular or regular-cycling Antral follicle count (AFC) >20 Age <35 years 4. ‘IVM is suitable for patients with normal ovaries; suitable for MF and Unexp patients’ - acceptable preg. rates (Suikkari, Finland) 5. Other (previous poor response to IVF, oocyte donation and fertility preservation for cancer patients) SLIDE 6 Standart ART Cycle

Clinical preparation of patients for IVM Protocol 1 (no stimulation) ET (day 3) U/S OR ICSI hCG 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 SLIDE 6 Standart ART Cycle U/S rFSH 150IU/day OR ICSI ET Protocol 2 (stimulation)

IVM oocyte retrieval Oocyte retrieval 36 hrs after hCG injection Performed under general anesthesia Oocyte aspiration as per standard IVF, aspiration pressure 7.5 – 8.0 KPa (85 – 100 mm Hg) using Cook aspiraton needle. 3 – 4 follicles aspirated, one after another Follicular fluid collected in tubes containing 2 ml of warm heparinised saline soln. (heparin 2 IU/ml). The needle is then flushed with warm heparinised saline Tube containing aspirate is handed to the embryologist SLIDE 6 Standart ART Cycle

McGill Reproductive Center, Royal Victoria Hospital Priming with hCG before retrieval of immature oocytes in women with infertility due to polycystic ovary syndrome Chian RC, Gülekli B, Buckett WM, Tan SL McGill Reproductive Center, Royal Victoria Hospital Montreal, Canada SLIDE 6 Standart ART Cycle N Engl J Med 1999; 341: 1624-1626

SLIDE 6 Standart ART Cycle

Chian RC et al., Hum Reprod 15: 165-170, 2000 SLIDE 6 Standart ART Cycle Chian RC et al., Hum Reprod 15: 165-170, 2000

McGill Reproductive Center, Royal Victoria Hospital, Montreal, Canada Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation Gulekli B, Buckett WM, Chian RC, Child TJ, Abdul-Jalil AK, Tan SL McGill Reproductive Center, Royal Victoria Hospital, Montreal, Canada SLIDE 6 Standart ART Cycle Fertil Steril. 2004 Nov;82:1458-1459

SLIDE 6 Standart ART Cycle

IVM of oocytes – laboratory procedure Oocytes washed 24 – 48 hrs culture Oocytes cultured in maturation medium Mature oocyte (M-2) Insemination SLIDE 6 Standart ART Cycle 16-18 hours Cleavage Insemination (ICSI) Fertilized oocytes (2PN) Embryos for Embryo Transfer

Optimal maturation media Essential components Optimal maturation media Synchronized endometrium SLIDE 6 Standart ART Cycle

Media used for IVM Type of medium Composition Usage SAGE - IVM media kit (ART-1600) IVM Washing Hepes-buffered O.R., ICSI medium IVM Oocyte Maturation Med Maturation culture IVM Development Cleavage Embryo culture cleavage SLIDE 6 Standart ART Cycle OR Medicult IVM system (Medicult no. 82214010) LAG medium Handling medium O.R. IVM medium Maturation med. Maturation culture

Synchronized endometrium Essential components Optimal maturation media Synchronized endometrium SLIDE 6 Standart ART Cycle

Endometrial Preparation Endometrial thickness on day of OPU < 6 mm 10 - 12 mg oestradiol 6 - 8 mm 8 - 10 mg oestradiol  8 mm 6mg oestradiol Progesterone support (200mg, bid, p.v) started following ICSI SLIDE 6 Standart ART Cycle

SLIDE 6 Standart ART Cycle

SLIDE 6 Standart ART Cycle

A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries Child TJ, Philips SJ, Abdul-Jalil AK, Gulekli B, Tan SL McGill Reproductive Center, Royal Victoria Hospital Montreal, Canada Obstet Gynecol 2002; 100:665-70 SLIDE 6 Standart ART Cycle

SLIDE 6 Standart ART Cycle

McGill Reproductive Center, Royal Victoria Hospital IN-VITRO MATURATION AND FERTILIZATION OF OOCYTES FROM UNSTIMULATED OVARIES: PREDICTING THE NUMBER OF IMMATURE OOCYTES RETRIEVED BY EARLY FOLLICULAR PHASE ULTRASOUND SCAN Tan SL, Child TJ, Gülekli B McGill Reproductive Center, Royal Victoria Hospital Montreal, Canada SLIDE 6 Standart ART Cycle Am J Obstet & Gynecol, 2002 ,186:684-9

Results No. of cycles 189 Total # of immature oocytes 1695 Viable # “ “ “ 1616 # M-II oocytes 1292 Maturation rate (%) 80.0 % # 2PN embryos 965 Fertilization rate (%) 74.7 % Mean # immature oocytes(SD) 9.0  7.0 SLIDE 6 Standart ART Cycle Am J Obstet & Gynecol, 2002 ,186:684-9

SLIDE 6 Standart ART Cycle

SLIDE 6 Standart ART Cycle

Embryology data from an IVM programme McGill DEU Average number of oocytes retrieved 14.2 13.4 Percentage of oocytes matured 76.8% 65.8% Percentage of oocytes fertilized 63.1% 64.2% Percentage of embryos cleaved 89.0% 87.5% Average number of embryos transferred 3.9 3.4 SLIDE 6 Standart ART Cycle

Outcomes from IVM programs Center No of cases Clinical Preg/ET Maria Hospital 419 32.7% (Korea, ’00-’02)a Memorial Hosp. 68 33.8% (Taiwan)a Hopital Antoine-B 17 23.5% (France, ’02-’03)a McGill Rep. Ctr. 66 32.3% (Canada, ’03)b DEU 34 28.5% SLIDE 6 Standart ART Cycle a Chian RC (2003), RBMonline 8(2): 148-66 b McGill Rep. Ctr. (2003), personal data

Sonuç PCO tespit edilen kadınlardaki daha yüksek gebelik oranları bu hastalara IVF yerine rutin tedavide IVM önerilmesini düşündürmelidir Daha önceki geleneksel IVF sikluslarına kötü cevap verenler (poor responders) ve kötü kaliteli embryolar elde edilmiş hastalarda IVM yararlı olabilir IVM özellikle polikistik overi olan ve oosit donörü olmaya hazırlanan kadınlar için avantajları nedeni ile daha caziptir, böylelikle donör sayısını artırabilir SLIDE 6 Standart ART Cycle

SLIDE 6 Standart ART Cycle Teşekkürler